XLON
FVA
Market cap97mUSD
Oct 30, Last price
141.00GBP
1D
-7.84%
1Q
9.73%
Jan 2017
-5.61%
IPO
-10.76%
Name
Carr's Group PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fevara plc is an agricultural enterprise with operations spanning the United Kingdom and international markets. Its primary agricultural division focuses on manufacturing and supplying a comprehensive range of animal nutrition products, including feed blocks, mineral supplements, and specialized boluses containing vital trace elements for livestock. These products are distributed under numerous reputable brands such as Crystalyx, Horslyx, SmartLic, Tracesure, and Animax, among others. In addition to its core farming-related activities, the company also maintains interests in financial services, property management, and engineering, alongside the production and distribution of various animal health solutions. Founded in 1831 and headquartered in Carlisle, UK, the company was formerly known as Carr's Group plc until its rebranding to Fevara plc in September 2025.
Related entities
Subsidiaries (2)
BENDALLS ENGINEERING LIMITED
Walischmiller Engineering GmbH
Key people
Joshua Hoopes
Chief Executive Officer, Executive Director · since 2025
David White
Chief Executive Officer, Executive Director · since 2023
Chief Financial Officer, Senior Manager · since 2023
Paula Robertson
Group General Counsel, Company Secretary · since 2025
Non-Executive Director · since 2024
Non-Executive Independent Chairman of the Board · since 2023
Non-Executive Independent Director · since 2022
Fiona Rodford
Non-Executive Independent Director · since 2024
Senior Non-Executive Independent Director · since 2023
Headquarters & legal address
WARWICK MILL BUSINESS CENTRE
WARWICK BRIDGE
CARLISLE, CMA CA4 8RR
GB
WARWICK BRIDGE
CARLISLE, CMA CA4 8RR
GB
Previous name
CARR'S GROUP PLC
Previous name
CARR'S MILLING INDUSTRIES PUBLIC LIMITED COMPANY
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑08 | 2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||